Prof Kaylene Simpson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
185 Scholarly works
16 Projects
HIGHLIGHTS
2026
Journal article
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.
DOI: 10.1002/path.700752026
Journal article
Abstract LB476: Combined inhibition of transcription initiation and histone deacetylation triggers blood cancer cell death
DOI: 10.1158/1538-7445.am2026-lb4762026
Journal article
Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
DOI: 10.1158/1538-7445.am2026-6012026
Journal article
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity
DOI: 10.1158/1535-7163.MCT-25-03062022
Research grants (ARC, NHMRC, MRFF)
Establishment of Novel, Neuronal-Cell Based, Therapeutic Screens for Alzheimer\2019s Disease Using Patients Stem Cells
2020
Research grants (ARC, NHMRC, MRFF)
High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
2020
Research Grant
Translating Patient Stem Cells Into Personalised Screens for Age-Related Macular Degeneration
RECENT SCHOLARLY WORKS
2026
Journal article
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status
DOI: 10.3390/ijms270417742025
Other
Figure S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
DOI: 10.1158/2159-8290.308595872025
Other
Figure S3 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
DOI: 10.1158/2159-8290.308595812025
Other
Figure S6 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
DOI: 10.1158/2159-8290.308595722025
Other
Supplementary Table S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
DOI: 10.1158/2159-8290.308595662025
Other
Figure S5 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
DOI: 10.1158/2159-8290.30859575
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
OMIX3: High-Capacity Integrated Multi-Omics
2023
Research grants (ARC, NHMRC, MRFF)
Repurposing Clinical Grade Medications for Treatment of Friedrich Ataxia Heart Disease